Compare INTZ & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTZ | TRIB |
|---|---|---|
| Founded | 1983 | 1992 |
| Country | United States | Ireland |
| Employees | 52 | N/A |
| Industry | Computer Communications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7M | 14.2M |
| IPO Year | 2020 | 1996 |
| Metric | INTZ | TRIB |
|---|---|---|
| Price | $0.73 | $0.70 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | ★ 136.6K | 132.2K |
| Earning Date | 05-12-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,015,000.00 | N/A |
| Revenue This Year | $25.34 | $13.51 |
| Revenue Next Year | $14.70 | $13.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.56 | N/A |
| 52 Week Low | $0.69 | $0.50 |
| 52 Week High | $2.64 | $3.44 |
| Indicator | INTZ | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 57.78 |
| Support Level | N/A | $0.69 |
| Resistance Level | $1.20 | $0.76 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 14.81 | 71.11 |
Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.